JPS59219205A - Production of expandable tablet - Google Patents

Production of expandable tablet

Info

Publication number
JPS59219205A
JPS59219205A JP9340383A JP9340383A JPS59219205A JP S59219205 A JPS59219205 A JP S59219205A JP 9340383 A JP9340383 A JP 9340383A JP 9340383 A JP9340383 A JP 9340383A JP S59219205 A JPS59219205 A JP S59219205A
Authority
JP
Japan
Prior art keywords
sodium
water
potassium
tablets
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP9340383A
Other languages
Japanese (ja)
Other versions
JPS642563B2 (en
Inventor
Masanori Oota
正典 太田
Masashi Nakamura
正志 中村
Hitoshi Sasahara
笹原 均
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP9340383A priority Critical patent/JPS59219205A/en
Publication of JPS59219205A publication Critical patent/JPS59219205A/en
Publication of JPS642563B2 publication Critical patent/JPS642563B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PURPOSE:To obtain an expandable tablet capable of dissolving in water while dropping and expanding on pouring into water without forming a zone with a high concentration of chlorine at the bottom of a container, by incorporating a dichloroisocyanurate with a carbonate, etc. as a foaming agent and a solid acid, compressing and granulating the resultant mixture, tableting the granulated mixture. CONSTITUTION:(A) Sodium or potassium dichloroisocyanurate having 20-300mu, preferably 40-150mu fine particle diameter is incorporated with (B) a salt selected from sodium or potassium hydrogencarbonate or sodium or potassium sesquicarbonate having the same particle diameter range and (C) a solid organic or inorganic acid having the same particle diameter range, and the resultant mixture is uniformly mixed, compressed and granulated by a dry pressure roll to give a granular material having preferably 200-3,300mu grain diameter, which is then tableted to afford the aimed expandable tablet. The mixing ratios of the respective components are as follows; 100pts.wt. component (A), 10-400pts.wt., preferably 20-200pts.wt. component (B) and 10-400pts.wt., preferably 20- 200pts.wt. component (C). In this case, proper expansion and dispersion performance can be imparted.

Description

【発明の詳細な説明】 本発明はジクロロイソシアヌル酸塩と発泡化剤よりなる
錠剤の製造方法に関する。更に詳しく述べると水中投入
後、短時間で発泡しながら完全に熔解し、該錠剤あるい
は崩壊した粒子が水底で長時間滞留することのない錠剤
の製造方法に関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention relates to a method for producing tablets comprising dichloroisocyanurate and an effervescent agent. More specifically, the present invention relates to a method for producing tablets that completely melt while foaming in a short period of time after being placed in water, and in which the tablets or disintegrated particles do not remain at the bottom of the water for a long time.

ここ数年来塩素化イソシアヌル酸ばその優れた貯蔵安定
性故に塩素剤として広(使われるようになった。特にこ
れ迄はプール水と浄化槽排水の殺菌が主たる用途であっ
たが、新しい傾向として一般家庭の風呂水清浄化剤、衣
類や台所用品の殺菌や漂白的な使い方、水溶液にして壁
、床のカビ取り洗浄や殺菌洗浄に、動物小屋や熱帯魚の
水槽を脱臭の目的で殺菌6u浄したり等、特に家庭の主
婦が安易に取扱える殺菌、漂白、脱臭を目的とした商品
として使われてきている。
In recent years, chlorinated isocyanuric acid has been widely used as a chlorine agent due to its excellent storage stability. Up until now, its main use was to sterilize pool water and septic tank wastewater, but a new trend is Use as a household bath water purifier, sterilize and bleach clothes and kitchen utensils, use as an aqueous solution to remove mold and sterilize walls and floors, and sterilize animal cages and tropical fish tanks for the purpose of deodorizing. It has been used as a product for sterilization, bleaching, and deodorization that can be easily handled, especially by housewives.

従来、この種の商品としては次亜塩素ナトリウム液と云
う事になっていたが、このものが持つ取扱い難さ故に、
出来ることなら使わないで済ませたいイメージの商品で
あった。すなわち強アルカリ性故に皮膚は熱論衣服に付
着しても損傷、劣化を起こし、又取扱い時には目の刺激
に悩まされ、目に入るような事にでもなれば極めて危険
である。
Previously, this type of product was called sodium hypochlorite solution, but due to the difficulty of handling this product,
It was a product that I wanted to avoid using if possible. In other words, because of its strong alkaline nature, it causes damage and deterioration to the skin even if it adheres to thermal clothing, and it also irritates the eyes when handled, making it extremely dangerous if it gets into the eyes.

また液状故にこぼしたり、容器の外側に41着させると
、塩素剤かつアルカリ剤である性質上非常に厄介である
。ところが、この次亜塩素酸ナトリウム液に代わる抗菌
力の広くて強い薬剤となると塩素系薬剤を除いて他に見
当らないのが現状であり、こうした背景下で次亜塩素酸
ナトリウム液に比べればはるかに取扱い易いものとして
塩素化イソシアヌル酸が注目され、いろいろな形状で使
われ始めてきた。例えば、塩素化イソシアヌル酸または
その塩の粉末、顆粒及び錠剤が通常知られている。
Also, since it is a liquid, spilling it or letting it get on the outside of the container would be very troublesome as it is both a chlorine agent and an alkaline agent. However, the current situation is that there is no other agent other than chlorine-based agents that can replace this sodium hypochlorite solution with broad and strong antibacterial activity, and under these circumstances, it is far more effective than sodium hypochlorite solution. Chlorinated isocyanuric acid has attracted attention as it is easy to handle, and has begun to be used in various forms. For example, powders, granules and tablets of chlorinated isocyanuric acid or its salts are commonly known.

粉末では溶解速度は大きいが、粉立ちによる目、鼻の刺
激や、水面での粉浮きの現象があり好ましくない。
Powders have a high dissolution rate, but are undesirable because they cause irritation to the eyes and nose and the powder floats on the water surface.

一方、顆粒や錠剤においては粉立ち、粉浮きは少ないが
、溶解が遅く、当然、水底だけが高い塩素濃度になりや
すく、有効成分の均一な拡散は期待てきない。
On the other hand, with granules and tablets, there is little dusting or powder floating, but dissolution is slow and, of course, only the bottom of the water tends to have a high chlorine concentration, so uniform diffusion of the active ingredient cannot be expected.

これに対して、特開昭55−155792号公報では塩
素化イソシアヌル酸組成物に繊維素グリコール酸カルシ
ウム等の崩壊剤を配合したる後に圧縮成型して得られる
錠剤を、特開昭56−142210号では結晶性有機カ
ルボン酸及びアルカリ金属炭酸塩より成る錠剤を提案し
ている。
On the other hand, in JP-A-55-155792, a tablet obtained by blending a disintegrant such as cellulose calcium glycolate with a chlorinated isocyanuric acid composition and then compression molding is disclosed in JP-A-56-142210. In this issue, a tablet consisting of a crystalline organic carboxylic acid and an alkali metal carbonate is proposed.

しかし、これらの錠剤は水底で単に崩壊するだけか、ま
たは水底で発泡し崩壊するだけで、粉または粒が水底で
沈積し何ら拡散の効果を有し無い事から水底、または水
槽の栓等を腐食させ易いものである。錠剤の熔解速度を
高める為に、粒子径の細かい粉末を用いて錠剤を得る事
が考えられるが、連続打錠にて錠剤を生産する場合、粉
の流動性や成型性が高いことが必要であり、この為には
粒径の大きい粒子を用いる必要がある。
However, these tablets simply disintegrate at the bottom of the water, or they simply foam and disintegrate at the bottom of the water, and the powder or grains settle at the bottom of the water and have no diffusion effect, so they cannot be used at the bottom of the water or at the stopper of the aquarium. It is easily corroded. In order to increase the dissolution rate of tablets, it is possible to obtain tablets using powder with a fine particle size, but when producing tablets by continuous tableting, it is necessary that the powder has high fluidity and moldability. Therefore, it is necessary to use particles with a large particle size.

この様に、活性塩素剤を主成分とする錠剤の水底での滞
留による弊害を無くずため、水中で発泡し上下動をしな
がら、はとんど水底に滞留すること無く、30〜60秒
で均一に熔解する発泡性顆粒の製造方法を既に特願昭5
8−2849.52号に出願中である。
In this way, in order to eliminate the harmful effects of tablets containing active chlorine agents remaining at the bottom of the water, they are foamed in water and moved up and down for 30 to 60 seconds without staying at the bottom of the water. A patent application has already been filed in 1973 for a method for producing expandable granules that are uniformly melted.
No. 8-2849.52 is pending.

しかし、この顆粒は発泡、/g解が進むと粒子1蚤が小
さくなり、水面上に浮上しやすく、分散性がやや低下す
る傾向がある。
However, as the granules are foamed and dissolved per gram, each particle becomes smaller and tends to float on the water surface, resulting in a slight decrease in dispersibility.

この発泡性顆粒の組成、粒子径等について鋭意研究の結
果、顆粒状の発泡剤と塩素化イソシアヌル酸塩の各々を
混合し、そのまま打錠した従来の発泡錠剤の熔解速度(
比較例を参照)よりはるかに速く、粉や粒子が発泡終了
後に水底に沈積しない錠剤を得る方法を見いだすに至っ
た。
As a result of extensive research into the composition, particle size, etc. of these effervescent granules, we found that the dissolution rate of conventional effervescent tablets made by mixing granular effervescent agents and chlorinated isocyanurate and compressing them into tablets as is (
We have now found a way to obtain tablets that are much faster than those described in Comparative Examples) and in which powders and particles do not settle to the bottom of the water after foaming is complete.

即ち、本発明は次の3成分(al、 (bl、及び(C
)(al  ジクロロイソシアヌル酸のナトリウムまた
はカリウム塩 (bl  炭酸水素ナトリウムまたはカリウム、セスキ
炭酸ナトリウムまたはカリウム、炭酸ナトリウムまたは
カリウムからなる群から選ばれた物(C)  固体の有
機酸または無機酸 を配合し、加圧ロールにより圧縮造粒して得る顆粒状物
を、錠剤化する事を特徴とする発泡性錠剤の製造方法で
ある。
That is, the present invention uses the following three components (al, (bl, and (C
) (al Sodium or potassium salt of dichloroisocyanuric acid (bl) A substance selected from the group consisting of sodium or potassium bicarbonate, sodium or potassium sesquicarbonate, sodium or potassium carbonate (C) Contains a solid organic or inorganic acid. , is a method for producing effervescent tablets, characterized in that granules obtained by compression granulation using a pressure roll are made into tablets.

更に詳しく述べると、20〜300μ好ましくは40〜
150μの微細粒径を有するジクロロイソシアヌル酸の
す1−リウムまたはカリウム塩に同粒径範囲の炭酸水素
すトリウムまたはカリウム、セスキ炭酸ナトリウムまた
はカリウム、炭酸ナトリウムまたはカリウムと固体の有
機酸または無機酸を均一に混合したる後に、加圧ロール
にて造粒を行って100〜4,000μ好ましくは20
0〜3,000μの粒径範囲の顆粒とし、該顆粒をタブ
レッティングマシンまたはブリケラティングマシンで成
型する発泡錠剤の製造方法である。
More specifically, 20 to 300 μ, preferably 40 to
Sodium or potassium salt of dichloroisocyanuric acid having a fine particle size of 150μ is mixed with sodium or potassium bicarbonate, sodium or potassium sesquicarbonate, sodium or potassium carbonate and a solid organic or inorganic acid in the same particle size range. After uniformly mixing, granulation is performed using a pressure roll to form particles of 100 to 4,000μ, preferably 20
This is a method for producing effervescent tablets, in which granules with a particle size range of 0 to 3,000 μ are formed and the granules are molded using a tabletting machine or a briquetting machine.

この際に造粒性をよくするために、ステアリン酸塩、タ
ルク、硼酸等の滑剤を加える事が好ましい。また配合物
中の水分はできる限り低水分の方が製品の保存安定性が
良い。水分含量は配合物中に1重量%以下が好ましい。
At this time, in order to improve granulation properties, it is preferable to add a lubricant such as stearate, talc, or boric acid. Furthermore, the storage stability of the product is better when the water content in the formulation is as low as possible. Preferably, the water content is less than 1% by weight in the formulation.

更に長期間の保存安定性を付与する場合は無水硼酸を添
加すると良い。
In order to impart further long-term storage stability, boric anhydride may be added.

これらの各々の配合原料の粒子径は20〜300μ、好
ましくは40〜200μを使用した方が混合と造粒化が
容易である。この粒子径の範囲以外では、粉の供給が円
滑でなく、均一な厚みや硬度を持つ顆粒が得られにくく
、またロールのスリップも起こり易く更には顆粒化の収
率が低くなる。
Mixing and granulation are easier when the particle size of each of these raw materials is 20 to 300 μm, preferably 40 to 200 μm. If the particle size is outside this range, the powder will not be fed smoothly, it will be difficult to obtain granules with uniform thickness and hardness, roll slip will easily occur, and the granulation yield will be low.

配合組成物中の固体酸としては、特に限定しないが、そ
の1%水溶液のI)Hが1.7〜4.0範囲のものが良
く、また吸湿性の小さい方が好ましい。これらに当ては
まる固体酸としてはクエン酸、酒石酸、アジピン酸、コ
ハク酸等の有機酸及び酸性リン酸塩等の無機酸がある。
The solid acid in the blended composition is not particularly limited, but it is preferable that the I)H value of a 1% aqueous solution thereof is in the range of 1.7 to 4.0, and it is preferable that the solid acid has low hygroscopicity. Solid acids applicable to these include organic acids such as citric acid, tartaric acid, adipic acid, and succinic acid, and inorganic acids such as acidic phosphates.

pH値がこの範囲外の酸では、例えばpH1’、7以下
では製品の安定性に乏しく、p H4以上の場合は発泡
が極めて小さく、実用に供しない。
If the pH value of the acid is outside this range, for example, if the pH value is 1' or less than 7, the stability of the product will be poor, and if the pH value is 4 or more, foaming will be extremely small and the product will not be of practical use.

また、配合物の配合割合は、塩素化イソシアヌル酸10
0重量部に対して、重炭酸塩、セスキ炭酸塩あるいは炭
酸塩は10〜400重量部、好ましくは20〜200重
量部で有り、固体酸は10〜400重量部、好ましくは
20〜200重量部で有る場合に適正な発泡、分散性能
を付与できる。
In addition, the blending ratio of the compound is 10% of chlorinated isocyanuric acid.
0 parts by weight, bicarbonate, sesquicarbonate or carbonate is 10 to 400 parts by weight, preferably 20 to 200 parts by weight, and solid acid is 10 to 400 parts by weight, preferably 20 to 200 parts by weight. Appropriate foaming and dispersion performance can be imparted when

滑剤は必要に応じて使用するが、滑剤の添加量は前記の
+a)、 (b)及び(C1の配合物100重量部に対
して0.01〜5重量部添加すれば良い。更に長期間の
保存安定性を付与する無水硼酸の添加量は塩素化イソシ
アヌル酸に対して1〜40重量部好ましくは1〜10重
量部添加すると良い。また・必要に応じて、増量剤、界
面活性剤、金属キレート化剤、防錆剤、色素等の補助剤
を添加することは本願の更に好ましい態様である。
A lubricant may be used as necessary, but the amount of lubricant to be added may be 0.01 to 5 parts by weight per 100 parts by weight of the above +a), (b) and (C1) formulations. The amount of boric anhydride that imparts storage stability is preferably 1 to 40 parts by weight, preferably 1 to 10 parts by weight, based on the chlorinated isocyanuric acid.Additionally, if necessary, fillers, surfactants, It is a further preferred embodiment of the present application to add auxiliary agents such as metal chelating agents, rust preventives, and pigments.

これらの配合物を均一に混合した後、乾式の加圧ロール
たとえばコンパクテイングマシンやブリケソティングマ
シンで加圧成型し、粗砕しr100〜4000μ好まし
くは200〜3300μの粒径に篩い分けして顆粒を得
、ブリケティングマシンあるいはタブレッティングマシ
ンにより目的の発泡性錠剤を得る。この錠剤の大きさは
目的と用途によって異なるが台所、風呂用等の家庭用と
しては、通常0.5〜10g/錠、貯溜水の殺菌、スラ
イムコントロール用としては5〜100g/錠が好まし
い。
After uniformly mixing these compounds, they are pressure-molded using a dry pressure roll such as a compacting machine or a briquetting machine, coarsely crushed, and sieved to a particle size of r100 to 4000μ, preferably 200 to 3300μ. Granules are obtained, and the desired effervescent tablets are obtained using a briquetting machine or a tabletting machine. The size of this tablet varies depending on the purpose and use, but it is usually 0.5 to 10 g/tablet for household use such as in the kitchen or bath, and 5 to 100 g/tablet for use in sterilizing stored water and controlling slime.

この様にして得られた発泡性錠剤は水中に投入すると、
水底に落下中発泡しながら1分がら3分以内に発泡終了
と共に溶解してしまう。錠剤であるから粉末の様に投入
時の粉立らも無い。これ程早く溶けるので、従来品の錠
剤の様に容器の底部に高濃度の塩素濃度帯域を作り出し
、それにより材質劣化を引き起したりする事も無く、更
に液体の塩素剤より取り扱いが容易である。
When the effervescent tablets obtained in this way are placed in water,
While falling to the bottom of the water, it foams and dissolves within 1 to 3 minutes after foaming ends. Since it is a tablet, there is no powder left behind when you put it in, unlike powder. Because it dissolves so quickly, it does not create a high chlorine concentration zone at the bottom of the container like conventional tablets, which causes material deterioration, and it is easier to handle than liquid chlorine agents. .

以下に比較例と実施例を挙げて、さらに本願発明の詳細
な説明するが、本願の技術的範囲はこれ−に限定される
ものでない。
The present invention will be further explained in detail with reference to comparative examples and examples, but the technical scope of the present application is not limited thereto.

実施例1 水分が1.00重量%以下で各配合物の粒子径が40〜
150μである、ジクロロイソシアヌル酸ナトリウム3
0重量%、炭酸水素すトリウム34.8重量%、酒石酸
35重量%、及びステアリン酸マグネシウム0.2重量
%を均一に混合シ、該配合物を加圧ロール式造粒機を用
いて薄板状成型物を得、これをブレーカにより粉砕した
後に、8メソシユ(2,400μ)パス、48メツシユ
(300μ)ストップに分級し顆粒状物を得た。
Example 1 Moisture is 1.00% by weight or less and the particle size of each formulation is 40~
Sodium dichloroisocyanurate 3, which is 150μ
0% by weight, 34.8% by weight of sodium bicarbonate, 35% by weight of tartaric acid, and 0.2% by weight of magnesium stearate, and the mixture was formed into a thin plate using a pressure roll granulator. A molded product was obtained, which was crushed using a breaker, and then classified into 8 mesh (2,400 μ) passes and 48 mesh (300 μ) stops to obtain granules.

そして得られた顆粒状物99.8重量%と8θμ以下の
ステアリン酸マグネシウム0.2重量%を均一に混合し
直径20龍の臼に3.0gを充填し   □た後、その
上に杵を入れ、油圧プレスにより面圧が600kg/c
IIYの圧力をかけ、圧縮成型して、径が20龍、厚み
が5.5鰭、密度が1.74g/C−の錠剤を得た。尚
、加圧ロール機の操作条件は以下の通りである。
Then, 99.8% by weight of the obtained granules and 0.2% by weight of magnesium stearate having a particle size of 8θμ or less were uniformly mixed and 3.0g was filled into a mortar with a diameter of 20 mm. The surface pressure is 600kg/c using a hydraulic press.
A pressure of IIY was applied and compression molding was performed to obtain a tablet having a diameter of 20 mm, a thickness of 5.5 mm, and a density of 1.74 g/C-. Note that the operating conditions of the pressure roll machine are as follows.

ロール;径160+u  幅6oII11フレーク厚み
;2.3〜3.2關 ロール回転数:15rpm 油圧;87kg/cJ、線圧;1,5t/cmこの様に
して得た錠剤の溶解速度を以下に記す方法で評価した所
、表−3にまとめて溶解速度の結果を示すが、95秒で
発泡と熔解が完了し、水底に粉の沈積はなっがた。
Roll; Diameter 160+U Width 6oII 11 flakes Thickness: 2.3-3.2 Roll rotation speed: 15 rpm Oil pressure: 87 kg/cJ, linear pressure: 1.5 t/cm The dissolution rate of the tablets obtained in this way is described below. As a result of the evaluation, the results of the dissolution rate are summarized in Table 3. Foaming and dissolution were completed in 95 seconds, and no powder was deposited on the bottom of the water.

(熔解速度評価法) 11のビー力に純水1. 000m1lヲ入tL、これ
を30に保ち、これに錠剤を静かに落とし、投入直後の
錠剤の発泡、崩壊、熔解状況を観察し、完全に溶解が完
了するまでの時間を測定する。
(Method for evaluating melting speed) 1. Bee power and 1. pure water. 000 ml/liter, maintained at 30 tL, drop the tablet gently into it, observe the foaming, disintegration, and melting status of the tablet immediately after adding it, and measure the time until complete dissolution is completed.

実施例2〜4 顆粒状物を得る時の配合物及び組成を表−1の様に変え
た以外は実施例1と同様に行った。得られた錠剤は厚み
が5.3〜5.6鮎で密度が1.7〜1.8g/cn(
であった。熔解速度の評価を表−3に示す。表の数値は
重量%である。
Examples 2 to 4 The same procedure as in Example 1 was carried out except that the formulation and composition for obtaining granules were changed as shown in Table 1. The obtained tablets had a thickness of 5.3 to 5.6 g/cm and a density of 1.7 to 1.8 g/cn (
Met. Evaluation of melting speed is shown in Table-3. The values in the table are in % by weight.

表−1配合組成 比較例1〜3 表−2の示す配合組成で、実施例1の顆粒化をせず、実
施例1と同じ打錠方法で錠剤を作り、実施例1と同じ方
法で溶解速度を測定した。その結果を表−3に示す。尚
、各配合物の水分含量は1重量%以下である。
Table-1 Composition Comparison Examples 1 to 3 Tablets were made using the same tableting method as Example 1 without granulation using the composition shown in Table-2, and dissolved using the same method as Example 1. The speed was measured. The results are shown in Table-3. Note that the water content of each formulation is 1% by weight or less.

表−2配合組成 ()内の数値は各配合物の粒度を表す。Table-2 Mixing composition The numbers in parentheses represent the particle size of each formulation.

表−3溶解速度の評価 表−3に示す様に本発明の錠剤は溶解速度が速く、発泡
終了と同時に溶は水底に粉の沈積が無い。
Table 3 Evaluation of Dissolution Rate As shown in Table 3, the tablets of the present invention have a fast dissolution rate, and no powder is deposited on the bottom of the water as soon as foaming is completed.

比較例に示゛4−顆粒化をしないで直接錠剤化したもの
は発泡終了後も未だ溶けず、水底に粉の沈積が有る。
Comparative Example 4 - Tablets that were directly made into tablets without being granulated remained undissolved even after foaming, and powder was deposited on the bottom of the water.

Claims (1)

【特許請求の範囲】 l)次あ3成分(al、 (b)、及び(0)(a) 
 ジクロロイソシアヌル酸のすトリウムまたはカリウム
塩 (bl  炭酸水素ナトリウムまたはカリウム、セスキ
炭酸ナトリウムまたはカリウム、炭酸ナトリウムまたは
カリウムからなる群から選ばれた物(C1固体の有機酸
または無機酸 を配合し、加圧ロールにより圧縮造粒して得る顆粒状物
を、錠剤化する事を特徴とする発泡性錠剤の製造方法。 2)配合する3成分(al、 (bl、及び(C1の粒
子径が20〜300μである事を特徴とする特許請求の
範囲第1項記載の発泡性錠剤の製造方法。 3)加圧ロールにより圧縮造粒して得る顆粒の粒子径が
100〜4,000μである事を特徴とする特許請求の
範囲第1項記載の発泡性錠剤の製造方法。
[Claims] l) The following three components (al, (b), and (0) (a)
Sodium or potassium salt of dichloroisocyanuric acid (bl) A salt selected from the group consisting of sodium or potassium hydrogen carbonate, sodium or potassium sesquicarbonate, sodium or potassium carbonate (C1) containing a solid organic or inorganic acid and pressurizing A method for producing effervescent tablets, which comprises tableting granules obtained by compression granulation using rolls. 2) The particle size of the three components (al, (bl, and C1) to be mixed is 20 to 300μ 3) A method for manufacturing an effervescent tablet according to claim 1, characterized in that the granules obtained by compression granulation using a pressure roll have a particle size of 100 to 4,000 μ. A method for producing an effervescent tablet according to claim 1.
JP9340383A 1983-05-27 1983-05-27 Production of expandable tablet Granted JPS59219205A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP9340383A JPS59219205A (en) 1983-05-27 1983-05-27 Production of expandable tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9340383A JPS59219205A (en) 1983-05-27 1983-05-27 Production of expandable tablet

Publications (2)

Publication Number Publication Date
JPS59219205A true JPS59219205A (en) 1984-12-10
JPS642563B2 JPS642563B2 (en) 1989-01-18

Family

ID=14081330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP9340383A Granted JPS59219205A (en) 1983-05-27 1983-05-27 Production of expandable tablet

Country Status (1)

Country Link
JP (1) JPS59219205A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575637A1 (en) * 1985-01-09 1986-07-11 Charbonnages Ste Chimique Effervescent disinfectant tablets
WO1987003002A1 (en) * 1985-11-08 1987-05-21 Takeda Chemical Industries, Ltd. Process for producing foaming composition
JPS62164601A (en) * 1986-01-13 1987-07-21 Earth Chem Corp Ltd Vermin-controlling agent
JP2015042739A (en) * 2013-07-25 2015-03-05 四国化成工業株式会社 Floatable foaming tablet

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05137291A (en) * 1991-11-08 1993-06-01 Mitsuba Electric Mfg Co Ltd Wire harness device of generator

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139628A (en) * 1975-05-28 1976-12-02 Nissan Chem Ind Ltd Isocyanuric acid trichloride tablet composition, degradative into gran ules
JPS56142210A (en) * 1980-04-09 1981-11-06 Shikoku Chem Corp Quickly soluble tablet having bactericidal, anti-infective and cleaning performance

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51139628A (en) * 1975-05-28 1976-12-02 Nissan Chem Ind Ltd Isocyanuric acid trichloride tablet composition, degradative into gran ules
JPS56142210A (en) * 1980-04-09 1981-11-06 Shikoku Chem Corp Quickly soluble tablet having bactericidal, anti-infective and cleaning performance

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2575637A1 (en) * 1985-01-09 1986-07-11 Charbonnages Ste Chimique Effervescent disinfectant tablets
WO1987003002A1 (en) * 1985-11-08 1987-05-21 Takeda Chemical Industries, Ltd. Process for producing foaming composition
JPS62164601A (en) * 1986-01-13 1987-07-21 Earth Chem Corp Ltd Vermin-controlling agent
JP2015042739A (en) * 2013-07-25 2015-03-05 四国化成工業株式会社 Floatable foaming tablet

Also Published As

Publication number Publication date
JPS642563B2 (en) 1989-01-18

Similar Documents

Publication Publication Date Title
US4692335A (en) Calcium hypochlorite tablet
US5753602A (en) Chlorine cleanser tabletting process and product
US3296069A (en) Solid shaped sterilizing, sanitizing, and disinfecting compositions
JP7376531B2 (en) Low solubility hypochlorite-containing tablets
DE60301856T2 (en) DILUTABLE CLEANING COMPOSITIONS AND ITS USES
US3213029A (en) Granular compositions containing trichlorocyanuric acid
EP0871698B1 (en) Method of producing breakage-resistant detergent tablets
JPS59219205A (en) Production of expandable tablet
US3325411A (en) Compositions containing chlorinated isocyanurates and methods for stabilizing and tabletting the same
JPH0827119A (en) Dimethylhydantoin halide-based formed article
JP4047951B2 (en) Bleached powder composition
JPS59155311A (en) Production of foamed granules
JPS60237001A (en) Formed composition for water treatment
JPH07277912A (en) Stable solid halogen agent composition and tablet of solid halogen agent
JP5985547B2 (en) Floating effervescent tablets
AU2003246045B2 (en) Compression molded product of quick-dissolving chlorinated isocyanuric acid
JP2643199B2 (en) Chloroisocyanurate composition
JPS6141487B2 (en)
JP2711983B2 (en) Disinfection tablets
JPH0153844B2 (en)
US20040046149A1 (en) Quatrepolymer tablet
EP2598620B1 (en) Detergent composition
JPS6323812A (en) Production of tablet
JPH01139511A (en) Production of composition containing chlorinated isocyanuric acid having high compounding stability
JPH0124762B2 (en)